Mucosal Interleukin-10 depletion in steroid-refractory Crohn's disease patients

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Previous studies suggested that Interleukin-10 (IL-10) depletion in Crohn's disease (CD) could predict outcome. Aim: To determine IL-10 in blood and at different intestinal locations in patients with active CD and to assess its potential prognostic capacity to identify aggressive CD. Methods: Twenty-three patients with CD were included. Ulcerative colitis (UC), infectious colitis and healthy individuals acted as controls. Serum and mucosal samples were taken at baseline and 1 month after steroid initiation in CD patients. Patients were classified according to steroid response. Control samples were obtained from different intestinal locations. IL-10 expression was measured with real-time polymerase chain reaction, immunofluorescence (intestine) and ELISA (serum, biopsy cultures' supernatants and tissue homogenates). Results: CD and UC showed an increase in IL-10 messenger RNA (mRNA) versus controls (p

Cite

CITATION STYLE

APA

Carrasco, A., Tristán, E., Fernández-Bañares, F., Martín-Cardona, A., Aceituno, M., Zabana, Y., … Esteve, M. (2022). Mucosal Interleukin-10 depletion in steroid-refractory Crohn’s disease patients. Immunity, Inflammation and Disease, 10(10). https://doi.org/10.1002/iid3.710

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free